Omniabio announced their expansion to the City of Hamilton at the Collision Conference in Toronto, one of the world’s largest tech conferences.
Omniabio a subsidiary of CCRM, will be bringing a $580 million, 250,000 sq ft facility into the city as well as 250 highly skilled workers. Omniabio will be Canada’s first commercial-scale contract development and manufacturing organization (CDMO) dedicated to gene and cell therapies. Their facility will be located at McMaster Innovation Park and will be an anchor to the growing life science and health innovation network in Hamilton.
Tune in below to hear the City of Hamilton Economic Development Team, CCRM and Omniabio discuss this strategic investment at Collision.
Read the press release here: Hamilton’s Life Sciences Sector Grows with Omniabio Biomanufacturing Hub – Invest in Hamilton
